摘要
目的 调查D二聚体定量试剂检测临床标本的性能,探讨开展质量评估的可能性.方法 分别使用STA Liatest、Innovance D-二聚体和HS500三种试剂检测149例临床标本血浆D二聚体,分为0.2~1.00、1.01~4.00和4.01 ~ 20 mg/L三浓度区间统计方法间的偏差和在中高值区间的相关性,并以cutoff值(0.5 mg/L)作为定性判断的依据判断阴性符合率.结果 Innovance、HS500与Liatest相比,低值区间偏差低于0.05 mg/L,中值区间偏差为0.75和0.87mg/L,高值区间2.18和1.82 mg/L;线性关系具有统计学意义,分别为y=1.14x+0.18(r=0.92,P<0.01)和y=0.96x+ 0.59(r=0.863,P<0.01).以0.5 mg/L为cutoff值,两者与Liatest相比的阴性符合率为91.4%和80%,总体符合率为94%和89%.结论 三种血浆D二聚体定量检测作静脉血栓定性的定性筛查时有较高符合率,同时其定量结果的一致性为开展质量评价提供了前提.
Objective To investigate performance of major quantitative reagents in plasma D-Dimer analysis from clinical patients,looking for the feasibility of quality assessment in D-dimer.Methods Plasma from 149 patients were collected and analyzed.Biases in 0.2 ~ 1.00,1.01 ~4.00 and 4.01 ~20 mg/L three consecutive levels of D-dimer concentration,correlations in higher level(> 1.0 mg/L) and correspondence around cutoff(0.5 mg/L)between methods are calculated.Results Compared with Liatest D-dimer,Biases from innovance and HS 500 are less than 0.05 in 0.2-1.00 mg/L,0.75 and 0.87 mg/L in median,2.18 and 1.82 mg/L in high level.The statistical linearity lie in y =1.14 x + 0.18(r =0.92,P <0.01)from innovance and y =0.96 x + 0.59(r =0.863,P < 0.01)from HS 500,negative coincidence rates are 91.4% and 80%,respectively,and higher total coincidence are 94% and 89%.Conclusion As measure in excluding diagnostic of venous thromboembolism,reagents investigated show their conformability on basis of clinical evaluation,and suggest the probability for quality assessment in D-Dimer.
出处
《血栓与止血学》
2014年第5期243-246,共4页
Chinese Journal of Thrombosis and Hemostasis
关键词
D二聚体
静脉栓塞
质量评价
D-dimer
Venous thromboembolism
Quality assessment